Evidence of treatment benefit: is seeing believing or obfuscation by statistics?

被引：1

作者：

Cutter, Gary ^{[1
]}

机构：

[1] Univ Alabama, Birmingham, AL 35294 USA

来源：

MULTIPLE SCLEROSIS | 2009年 / 15卷 / 11期

关键词：

D O I：

10.1177/1352458509350169

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：1251 / 1252

页数：2

相关论文

共 2 条

[1] Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation [J].

Veugelers, P. J. ;

Fisk, J. D. ;

Brown, M. G. ;

Stadnyk, K. ;

Sketris, I. S. ;

Murray, T. J. ;

Bhan, V. .

MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (11) :1286-1294

[2] THE NATURAL-HISTORY OF MULTIPLE-SCLEROSIS - A GEOGRAPHICALLY BASED STUDY .4. APPLICATIONS TO PLANNING AND INTERPRETATION OF CLINICAL THERAPEUTIC TRIALS [J].

WEINSHENKER, BG ;

RICE, GPA ;

NOSEWORTHY, JH ;

CARRIERE, W ;

BASKERVILLE, J ;

EBERS, GC .

BRAIN, 1991, 114 :1057-1067